Which Is the Ideal Treatment for Benign Diffuse and Multinodular Non-Toxic Goiters?

Imagem de Miniatura
Arquivos
art_KNOBEL_Which_Is_the_Ideal_Treatment_for_Benign_Diffuse_2016.PDF (160.68 KB)
Citações na Scopus
14
Tipo de produção
article
Data de publicação
2016
Editora
FRONTIERS MEDIA SA
DOI
Indexadores
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
FRONTIERS IN ENDOCRINOLOGY, v.7, article ID 48, 8p, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Patients with large benign goiters often present local compressive symptoms that require surgical treatment, including dysphagia, neck tightness, and airway obstruction. In contrast, patients with such goiters who remain asymptomatic may be observed after exclusion of malignancy. The use of levothyroxine (LT4) to reduce the volume of the goiter is still a controversial treatment for large goiters, and the optimal surgical procedure for multinodular goiter is still debatable. Radioiodine is a safe and effective treatment option when used alone or in combination with recombinant human TSH. This review discusses current therapeutic options to treat diffuse and multinodular nontoxic benign goiters.
Palavras-chave
benign goiter, non-toxic, diffuse, multinodular, treatment
URI
https://observatorio.fm.usp.br/handle/OPI/16409
Referências
  1. Agarwal G, 2008, WORLD J SURG, V32, P1313, DOI 10.1007/s00268-008-9579-8
  2. Albino C, 2008, EXPERT OPIN INV DRUG, V17, P1781, DOI 10.1517/13543780802501325
  3. Baehr KM, 2012, LARYNGOSCOPE, V122, P834, DOI 10.1002/lary.23186
  4. Bauer PS, 2013, J SURG RES, V184, P514, DOI 10.1016/j.jss.2013.04.045
  5. BERGHOUT A, 1989, CLIN ENDOCRINOL, V31, P193, DOI 10.1111/j.1365-2265.1989.tb01242.x
  6. BERGHOUT A, 1990, LANCET, V336, P193, DOI 10.1016/0140-6736(90)91730-X
  7. BISTRUP C, 1994, CLIN ENDOCRINOL, V40, P323
  8. Bonnema SJ, 1999, J CLIN ENDOCR METAB, V84, P3636, DOI 10.1210/jc.84.10.3636
  9. Bonnema SJ, 2007, J CLIN ENDOCR METAB, V92, P3424, DOI 10.1210/jc.2007-0501
  10. Bonnema SJ, 2012, ENDOCR REV, V33, P920, DOI 10.1210/er.2012-1030
  11. Bonnema SJ, 2014, BEST PRACT RES CL EN, V28, P619, DOI 10.1016/j.beem.2014.02.001
  12. Castro MR, 2002, J CLIN ENDOCR METAB, V87, P4154, DOI 10.1210/jc.2001-011762
  13. Cirocchi R, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010370.pub2
  14. Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110
  15. Diehl LA, 2005, J CLIN ENDOCR METAB, V90, P117, DOI 10.1210/jc.2004-1722
  16. Fast S, 2009, EUR J ENDOCRINOL, V160, P517, DOI 10.1530/EJE-08-0779
  17. Fast S, 2012, J CLIN ENDOCR METAB, V97, P2653, DOI 10.1210/jc.2011-3335
  18. Fiore E, 2010, ENDOCR-RELAT CANCER, V17, P231, DOI 10.1677/ERC-09-0251
  19. GEERDSEN JP, 1986, ACTA MED SCAND, V220, P341
  20. Graf H, 2011, J CLIN ENDOCR METAB, V96, P1368, DOI 10.1210/jc.2010-1193
  21. Graf H, 2015, EUR J ENDOCRINOL, V172, DOI 10.1530/EJE-14-0608
  22. Grussendorf M, 2011, J CLIN ENDOCR METAB, V96, P2786, DOI 10.1210/jc.2011-0356
  23. Gullu S, 1999, ENDOCR J, V46, P221, DOI 10.1507/endocrj.46.221
  24. Hegedus L, 1999, J CLIN ENDOCR METAB, V84, P756, DOI 10.1210/jc.84.2.756
  25. Hegedus L, 1997, LANCET, V350, P409, DOI 10.1016/S0140-6736(05)64132-3
  26. HEGEDUS L, 1988, BRIT MED J, V297, P661
  27. Hegedus L, 2003, ENDOCR REV, V24, P102, DOI 10.1210/er.2002-0016
  28. Hintze G, 1992, Thyroidology, V4, P37
  29. Howarth DM, 1997, EUR J NUCL MED, V24, P1465, DOI 10.1007/s002590050175
  30. HUYSMANS DAKC, 1994, ANN INTERN MED, V121, P757
  31. Huysmans DAKC, 1996, J NUCL MED, V37, P2072
  32. Knobel M, 2016, J ENDOCRINOL INVEST, V39, P357, DOI 10.1007/s40618-015-0391-7
  33. Krohn K, 2005, ENDOCR REV, V26, P504, DOI 10.1210/er.2004-0005
  34. Medeiros-Neto G, 2008, ENDOCRINE, V33, P109, DOI 10.1007/s12020-008-9077-7
  35. Mercante G, 2010, HEAD NECK-J SCI SPEC, V33, P792
  36. MICCOLI P, 1993, SURGERY, V114, P1097
  37. Moalem J, 2008, WORLD J SURG, V32, P1301, DOI 10.1007/s00268-008-9477-0
  38. Nielsen VE, 2005, J CLIN ENDOCR METAB, V90, P79, DOI 10.1210/jc.2004-1550
  39. Nielsen VE, 2006, ARCH INTERN MED, V166, P1476, DOI 10.1001/archinte.166.14.1476
  40. Nygaard B, 1997, J CLIN ENDOCR METAB, V82, P2926, DOI 10.1210/jc.82.9.2926
  41. Nygaard B, 1997, CLIN ENDOCRINOL, V46, P493, DOI 10.1046/j.1365-2265.1997.1760987.x
  42. Paz-Filho GJ, 2007, BRAZ J MED BIOL RES, V40, P1661, DOI 10.1590/S0100-879X2007001200010
  43. Peters H, 1997, MED KLIN, V92, P63
  44. Pieracci FM, 2007, J AM COLL SURGEONS, V205, P1, DOI 10.1016/j.jamcollsurg.2007.03.010
  45. Puzziello A, 2014, J ENDOCRINOL INVEST, V37, P1181, DOI 10.1007/s40618-014-0128-z
  46. RIEU M, 1993, CLIN ENDOCRINOL, V39, P67, DOI 10.1111/j.1365-2265.1993.tb01752.x
  47. ROJDMARK J, 1995, EUR J SURG, V161, P725
  48. Romao R, 2009, THYROID, V19, P945, DOI 10.1089/thy.2008.0394
  49. ROSS DS, 1992, THYROID, V2, P263, DOI 10.1089/thy.1992.2.263
  50. Rubio IGS, 2005, THYROID, V15, P134, DOI 10.1089/thy.2005.15.134
  51. Samuels MH, 2001, J CLIN ENDOCR METAB, V86, P994, DOI 10.1210/jc.86.3.994
  52. Thomusch O, 2000, WORLD J SURG, V24, P1335
  53. Uzzan B, 1996, J CLIN ENDOCR METAB, V81, P4278, DOI 10.1210/jc.81.12.4278
  54. VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x
  55. Wesche MFT, 2001, J CLIN ENDOCR METAB, V86, P998, DOI 10.1210/jc.86.3.998
  56. Yoldas T, 2015, INT SURG, V100, P9, DOI 10.9738/INTSURG-D-13-00275.1

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/25